Definium Therapeutics, Inc. (DFTX)
29.12
-0.26
(-0.88%)
USD |
NASDAQ |
Nov 18, 16:00
28.71
-0.41
(-1.41%)
After-Hours: 18:33
Definium Therapeutics Price to Book Value : 4.118 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 4.155 |
| November 16, 2026 | 4.265 |
| November 13, 2026 | 4.536 |
| November 12, 2026 | 4.666 |
| November 11, 2026 | 4.874 |
| November 10, 2026 | 4.898 |
| November 09, 2026 | 5.004 |
| November 06, 2026 | 4.705 |
| November 05, 2026 | 4.293 |
| November 04, 2026 | 4.624 |
| November 03, 2026 | 4.724 |
| November 02, 2026 | 4.592 |
| October 30, 2026 | 5.137 |
| October 29, 2026 | 5.368 |
| October 28, 2026 | 5.388 |
| October 27, 2026 | 5.243 |
| October 26, 2026 | 5.045 |
| October 23, 2026 | 5.044 |
| October 22, 2026 | 5.091 |
| October 21, 2026 | 5.019 |
| October 20, 2026 | 4.962 |
| October 19, 2026 | 4.662 |
| October 16, 2026 | 4.539 |
| October 15, 2026 | 4.845 |
| October 14, 2026 | 4.842 |
| Date | Value |
|---|---|
| October 13, 2026 | 4.862 |
| October 12, 2026 | 4.978 |
| October 09, 2026 | 5.218 |
| October 08, 2026 | 4.833 |
| October 07, 2026 | 4.962 |
| October 06, 2026 | 5.037 |
| October 05, 2026 | 5.123 |
| October 02, 2026 | 5.289 |
| October 01, 2026 | 5.317 |
| September 30, 2026 | 5.382 |
| September 29, 2026 | 5.589 |
| September 28, 2026 | 5.618 |
| September 25, 2026 | 5.290 |
| September 24, 2026 | 5.372 |
| September 23, 2026 | 5.507 |
| September 22, 2026 | 5.897 |
| September 21, 2026 | 5.745 |
| September 18, 2026 | 5.676 |
| September 17, 2026 | 5.657 |
| September 16, 2026 | 5.536 |
| September 15, 2026 | 5.385 |
| September 14, 2026 | 5.887 |
| September 11, 2026 | 5.688 |
| September 10, 2026 | 5.518 |
| September 09, 2026 | 5.556 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Enliven Therapeutics, Inc. | 3.768 |
| Cocrystal Pharma, Inc. | 6.986 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.8630 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1791 |
| Price | 29.12 |
| Earnings Yield | -10.41% |
| Market Cap | 3.986B |
| PEGY Ratio | -0.1791 |